January 31, 2011 – An oncology systems provider has launched The Year of Radiotherapy, an initiative to raise awareness of radiotherapy as a cost-effective, cutting-edge treatment that can help cure cancer. Oncology Systems Limited (OSL) launched the program in response to data from Cancer Research UK.

According to figures published by Cancer Research UK, only one in 10 people know that radiotherapy helps cure 40 percent of cancer patients. A report from the national charity estimates that only 38 percent of cancer patients in England are getting radiotherapy, although research shows that up to 50 percent might benefit.

"We need to dispel the myths about radiotherapy and associated side effects and make people more aware of the benefits of the latest treatments,” said Julie Mead, clinical director of OSL. “But we also need to make sure that these treatments are available across the country. The U.K. lags behind America and Europe in introducing the new, more targeted radiotherapy technology that is available. Rather than update and reinvest in technology that's essentially been around for the last 40 or so years, it's time we made sure that every cancer patient in the U.K. has access to the best treatment."

"There's no doubt that our survival rates have risen and our treatment has improved almost beyond recognition,” said Sir Mike Richards, who launched OSL’s latest TomoTherapy installation at Nottingham City Hospital. “Our aim is to match the best in the world. With the TomoTherapy machine there will be treatments that people from the East Midlands and beyond will be able to access for the first time. I'm sure people from other trusts will come here to look for ideas for future treatment."

OSL is the U.K. and Ireland's exclusive distributor of the helical TomoTherapy treatment machine, which provides precise, targeted, image guided intensity modulated radiotherapy. There are more than 300 installations of the machine worldwide, but just six hospitals using the technology in the U.K.

For more information: www.osl.uk.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now